Patent Assignment
Reel/Frame 040669/0700
Assignment of Assignor's Interest
Recorded: 2016-12-19
Pages: 7
Assignors
HEARTLEIN, MICHAEL
Executed: 2016-12-05
DEROSA, FRANK
Executed: 2016-12-05
SMITH, LIANNE
Executed: 2016-12-12
Assignee
SHIRE HUMAN GENETIC THERAPIES, INC.
300 SHIRE WAY, LEXINGTON, MASSACHUSETTS, 02421
Covered Property
(1)
Messenger RNA Therapy for the Treatment of Ornithine Transcarbamylase Deficiency
Application:
62/349,331 →
Related Assignments
(2)
Other recorded transfers of the patent in this record — the chain of ownership.